 Is the body giving off other indications, like a fever does, that something's going to miss? There are any other things in the blood, unmetablas and the gut biome, that you can detect before you can see the cells. And if you have enough patients, it can say, oh, given this combination of phenomics, different indications in the body, something's going on. And given history of patients, it looks like you might be pre-cancerous. Because the body's reacting, it knows something's missed, we don't have the tools yet to see it, but oh, your body's giving a tell. And this next thing we call phenomics, where I spend a lot of time at Google, is figuring out, well, my goodness, how do you reason with that, and what's the cloud to perform that? And how do you make that as easy as like just typing into a prompt, right, and are asking a bot, getting an answer? I mean, that's the tool. And that's going to be available to everybody, every oncologist. And so the idea is you're doing a summary, and it goes, you should probably do a sequencing test. What's an NGS on next generation sequencing? Tap for more. And it comes in, it goes, you want a digital diagnostic? What's that? Oh, I can run a test to figure out, right now, while you're waiting, what's the correlate that might be pre-cancerous? Because we're seeing some indications that, like, I'll order that. Complete digital, because it's already been safely, securely provided. And that's where it's headed. Imagining any test results, like, within minutes, what they're doing is they're looking at a digital version of the patient and a digital data that can help you diagnostic. And I think the point here is that much like Zoom helps you with patients, imagine this in your hands. So now your patient, there's always something over your shoulder saying, have you thought about? Have you considered? Here's a test you might want to consider, where you make the decision. You do the diagnosis. That's truly helpful.